At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GSK GlaxoSmithKline PLC
Pre-Market Trading 11-22 09:18:47 EST
33.70
+0.35
+1.05%
盘前33.79
+0.09+0.27%
08:49 EST
High33.70Low33.18Vol7.03M
Open33.40D1 Closing33.35Amplitude1.57%
Mkt Cap68.76BTradable Cap67.67BTotal Shares2.04B
T/O235.37MT/O Rate0.35%Tradable Shares2.01B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
GSK's RSV Vaccine Approved for Japanese Patients in Their 50s
MT Newswires Live  ·  20:05
GSK's RSV Vaccine Approved for Japanese Patients in Their 50s
GSK Expands RSV Vaccine Approval in Japan
TIPRANKS  ·  15:14
GSK Expands RSV Vaccine Approval in Japan
Scott Power: Global health markets wobble as Trump picks RFK Jr for top health role
Stockheads  ·  12:30
Scott Power: Global health markets wobble as Trump picks RFK Jr for top health role
Science 37 nearly doubles U.S. enrollment for GSK Phase 3 rare disease trial
TIPRANKS  ·  11-21 21:11
Science 37 nearly doubles U.S. enrollment for GSK Phase 3 rare disease trial
Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
GlobeNewswire  ·  11-21 21:00
Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
CDC warns of an imminent spike in COVID, flu cases
seekingalpha  ·  11-21 04:17
CDC warns of an imminent spike in COVID, flu cases
Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study
Zacks  ·  11-20 02:54
Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study
GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
Benzinga  ·  11-20 02:24
GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
GSK reports positive Phase 3 results for linerixibat in PBC itching
seekingalpha  ·  11-20 00:01
GSK reports positive Phase 3 results for linerixibat in PBC itching
GSK Executives Acquire ADSs, Aligning Interests with Shareholders
TIPRANKS  ·  11-19 23:32
GSK Executives Acquire ADSs, Aligning Interests with Shareholders
GSK Says Trial of Itch Treatment Linerixibat Meets Primary Endpoint
MT Newswires Live  ·  11-19
GSK Says Trial of Itch Treatment Linerixibat Meets Primary Endpoint
GSK announces phase III trial of linerixibat met primary endpoint
TIPRANKS  ·  11-19
GSK announces phase III trial of linerixibat met primary endpoint
BRIEF-GSK Meets Primary Endpoint in Late-Stage Trial To Treat Relentless Itch
Reuters  ·  11-19
BRIEF-GSK Meets Primary Endpoint in Late-Stage Trial To Treat Relentless Itch
GSK’s Linerixibat Shows Promise for PBC Itch Relief
TIPRANKS  ·  11-19
GSK’s Linerixibat Shows Promise for PBC Itch Relief
Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
Dow Jones  ·  11-18
Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
Vaccine stocks drop on concerns about RFK Jr. heading HHS (update)
seekingalpha  ·  11-16
Vaccine stocks drop on concerns about RFK Jr. heading HHS (update)
Stock Market Today: Dow Jones Slumps 250 Points As Yields Spike; Warren Buffett Targets Pizza, Pools With New Buys (Live Coverage)
Blockhead  ·  11-15
Stock Market Today: Dow Jones Slumps 250 Points As Yields Spike; Warren Buffett Targets Pizza, Pools With New Buys (Live Coverage)
Vaccine Maker Stocks Fall as Trump Chooses RFK Jr. to Lead HHS
Tiger Newspress  ·  11-15
Vaccine Maker Stocks Fall as Trump Chooses RFK Jr. to Lead HHS
Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
Yahoo Finance  ·  11-15
Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
Trump's RFK Pick Weighs on Vaccine Makers -- WSJ
Dow Jones  ·  11-15
Trump's RFK Pick Weighs on Vaccine Makers -- WSJ

Introduction

Company Name.
GlaxoSmithKline PLC
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
Issue price:
--